Current studies have reported that CSP has therapeutic potential for the treatment of NAFLD because it ameliorates insulin resistance, lipid peroxidation, steatohepatitis, etc,8, 9, 10 but the chemical components and functional mechanisms of CSP have not been fully studied. The gene discussed is DNAJC5; the disease is metabolic dysfunction-associated steatotic liver disease.